doxapram has been researched along with Benign Intracranial Hypertension in 1 studies
Doxapram: A central respiratory stimulant with a brief duration of action. (From Martindale, The Extra Pharmocopoeia, 30th ed, p1225)
doxapram : A member of the class of pyrrolidin-2-ones that is N-ethylpyrrolidin-2-one in which both of the hydrogens at the 3 position (adjacent to the carbonyl group) are substituted by phenyl groups, and one of the hydrogens at the 4 position is substituted by a 2-(morpholin-4-yl)ethyl group. A central and respiratory stimulant with a brief duration of action, it is used (generally as the hydrochloride or the hydrochloride hydrate) as a temporary treatment of acute respiratory failure, particularly when superimposed on chronic obstructive pulmonary disease, and of postoperative respiratory depression. It has also been used for treatment of postoperative shivering.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Namba, H | 1 |
Akimoto, M | 1 |
Yamaura, A | 1 |
Hagihara, Y | 1 |
Makino, H | 1 |
Sakurai, K | 1 |
1 other study available for doxapram and Benign Intracranial Hypertension
Article | Year |
---|---|
Effects of a respiratory stimulant on intracranial pressure and cerebral blood flow.
Topics: Animals; Cats; Cerebrovascular Circulation; Doxapram; Female; Intracranial Pressure; Male; Pseudotum | 1983 |